Effects of Pharmacological Treatment on Telomere Length and the Expression of Telomerase/Shelterin-Related Genes in Rat Models of Autism
Telomeres are increasingly recognized for their potential role in the etiology of autism spectrum disorder (ASD) due to their involvement in cellular aging and telomerase-shelterin function. Although shorter telomeres have been observed in individuals with ASD, studies linking telomere dynamics in b...
Saved in:
Published in | Journal of molecular neuroscience Vol. 75; no. 2; p. 55 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Springer US
24.04.2025
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Telomeres are increasingly recognized for their potential role in the etiology of autism spectrum disorder (ASD) due to their involvement in cellular aging and telomerase-shelterin function. Although shorter telomeres have been observed in individuals with ASD, studies linking telomere dynamics in blood cells and brain regions remain limited. Using the valproic acid (VPA, 500 mg/kg) rodent model, this study aimed to assess the impact of three drugs commonly used in ASD treatment (amitriptyline, risperidone, and nooclerin) on telomere length and the expression of telomerase/shelterin-related genes (
Dkc1
,
Gar1
,
Pot1a
,
Pot1b
,
Tep1
,
Terc
,
Terf2ip
,
Tert
,
Tinf2
,
Tnks
,
Tpp1
,
Trf1
, and
Trf2
) in blood cells, the prefrontal cortex, and hippocampus of VPA-exposed Wistar rats. Telomere length and gene expression were measured using quantitative PCR. Risperidone treatment in VPA males resulted in telomere elongation and increased expression of
Tnks
in blood cell and
Trf1
,
Trf2
genes in prefrontal cortex. Nooclerin treatment also showed beneficial effects on telomere length of blood cell in males, alongside increased
Trf1
expression. Long telomeres in male blood cells were associated with reduced anxiety, while a positive correlation was found between
Tpp1
expression and stereotypical behavior in both male and female VPA rats. These findings suggest that nooclerin and risperidone influence telomere length and gene expression related to the telomere-telomerase complex in a sex-dependent manner, offering insights into the neurobiological mechanisms underlying ASD. |
---|---|
AbstractList | Telomeres are increasingly recognized for their potential role in the etiology of autism spectrum disorder (ASD) due to their involvement in cellular aging and telomerase-shelterin function. Although shorter telomeres have been observed in individuals with ASD, studies linking telomere dynamics in blood cells and brain regions remain limited. Using the valproic acid (VPA, 500 mg/kg) rodent model, this study aimed to assess the impact of three drugs commonly used in ASD treatment (amitriptyline, risperidone, and nooclerin) on telomere length and the expression of telomerase/shelterin-related genes (Dkc1, Gar1, Pot1a, Pot1b, Tep1, Terc, Terf2ip, Tert, Tinf2, Tnks, Tpp1, Trf1, and Trf2) in blood cells, the prefrontal cortex, and hippocampus of VPA-exposed Wistar rats. Telomere length and gene expression were measured using quantitative PCR. Risperidone treatment in VPA males resulted in telomere elongation and increased expression of Tnks in blood cell and Trf1, Trf2 genes in prefrontal cortex. Nooclerin treatment also showed beneficial effects on telomere length of blood cell in males, alongside increased Trf1 expression. Long telomeres in male blood cells were associated with reduced anxiety, while a positive correlation was found between Tpp1 expression and stereotypical behavior in both male and female VPA rats. These findings suggest that nooclerin and risperidone influence telomere length and gene expression related to the telomere-telomerase complex in a sex-dependent manner, offering insights into the neurobiological mechanisms underlying ASD. Telomeres are increasingly recognized for their potential role in the etiology of autism spectrum disorder (ASD) due to their involvement in cellular aging and telomerase-shelterin function. Although shorter telomeres have been observed in individuals with ASD, studies linking telomere dynamics in blood cells and brain regions remain limited. Using the valproic acid (VPA, 500 mg/kg) rodent model, this study aimed to assess the impact of three drugs commonly used in ASD treatment (amitriptyline, risperidone, and nooclerin) on telomere length and the expression of telomerase/shelterin-related genes (Dkc1, Gar1, Pot1a, Pot1b, Tep1, Terc, Terf2ip, Tert, Tinf2, Tnks, Tpp1, Trf1, and Trf2) in blood cells, the prefrontal cortex, and hippocampus of VPA-exposed Wistar rats. Telomere length and gene expression were measured using quantitative PCR. Risperidone treatment in VPA males resulted in telomere elongation and increased expression of Tnks in blood cell and Trf1, Trf2 genes in prefrontal cortex. Nooclerin treatment also showed beneficial effects on telomere length of blood cell in males, alongside increased Trf1 expression. Long telomeres in male blood cells were associated with reduced anxiety, while a positive correlation was found between Tpp1 expression and stereotypical behavior in both male and female VPA rats. These findings suggest that nooclerin and risperidone influence telomere length and gene expression related to the telomere-telomerase complex in a sex-dependent manner, offering insights into the neurobiological mechanisms underlying ASD. Telomeres are increasingly recognized for their potential role in the etiology of autism spectrum disorder (ASD) due to their involvement in cellular aging and telomerase-shelterin function. Although shorter telomeres have been observed in individuals with ASD, studies linking telomere dynamics in blood cells and brain regions remain limited. Using the valproic acid (VPA, 500 mg/kg) rodent model, this study aimed to assess the impact of three drugs commonly used in ASD treatment (amitriptyline, risperidone, and nooclerin) on telomere length and the expression of telomerase/shelterin-related genes (Dkc1, Gar1, Pot1a, Pot1b, Tep1, Terc, Terf2ip, Tert, Tinf2, Tnks, Tpp1, Trf1, and Trf2) in blood cells, the prefrontal cortex, and hippocampus of VPA-exposed Wistar rats. Telomere length and gene expression were measured using quantitative PCR. Risperidone treatment in VPA males resulted in telomere elongation and increased expression of Tnks in blood cell and Trf1, Trf2 genes in prefrontal cortex. Nooclerin treatment also showed beneficial effects on telomere length of blood cell in males, alongside increased Trf1 expression. Long telomeres in male blood cells were associated with reduced anxiety, while a positive correlation was found between Tpp1 expression and stereotypical behavior in both male and female VPA rats. These findings suggest that nooclerin and risperidone influence telomere length and gene expression related to the telomere-telomerase complex in a sex-dependent manner, offering insights into the neurobiological mechanisms underlying ASD.Telomeres are increasingly recognized for their potential role in the etiology of autism spectrum disorder (ASD) due to their involvement in cellular aging and telomerase-shelterin function. Although shorter telomeres have been observed in individuals with ASD, studies linking telomere dynamics in blood cells and brain regions remain limited. Using the valproic acid (VPA, 500 mg/kg) rodent model, this study aimed to assess the impact of three drugs commonly used in ASD treatment (amitriptyline, risperidone, and nooclerin) on telomere length and the expression of telomerase/shelterin-related genes (Dkc1, Gar1, Pot1a, Pot1b, Tep1, Terc, Terf2ip, Tert, Tinf2, Tnks, Tpp1, Trf1, and Trf2) in blood cells, the prefrontal cortex, and hippocampus of VPA-exposed Wistar rats. Telomere length and gene expression were measured using quantitative PCR. Risperidone treatment in VPA males resulted in telomere elongation and increased expression of Tnks in blood cell and Trf1, Trf2 genes in prefrontal cortex. Nooclerin treatment also showed beneficial effects on telomere length of blood cell in males, alongside increased Trf1 expression. Long telomeres in male blood cells were associated with reduced anxiety, while a positive correlation was found between Tpp1 expression and stereotypical behavior in both male and female VPA rats. These findings suggest that nooclerin and risperidone influence telomere length and gene expression related to the telomere-telomerase complex in a sex-dependent manner, offering insights into the neurobiological mechanisms underlying ASD. Telomeres are increasingly recognized for their potential role in the etiology of autism spectrum disorder (ASD) due to their involvement in cellular aging and telomerase-shelterin function. Although shorter telomeres have been observed in individuals with ASD, studies linking telomere dynamics in blood cells and brain regions remain limited. Using the valproic acid (VPA, 500 mg/kg) rodent model, this study aimed to assess the impact of three drugs commonly used in ASD treatment (amitriptyline, risperidone, and nooclerin) on telomere length and the expression of telomerase/shelterin-related genes ( Dkc1 , Gar1 , Pot1a , Pot1b , Tep1 , Terc , Terf2ip , Tert , Tinf2 , Tnks , Tpp1 , Trf1 , and Trf2 ) in blood cells, the prefrontal cortex, and hippocampus of VPA-exposed Wistar rats. Telomere length and gene expression were measured using quantitative PCR. Risperidone treatment in VPA males resulted in telomere elongation and increased expression of Tnks in blood cell and Trf1 , Trf2 genes in prefrontal cortex. Nooclerin treatment also showed beneficial effects on telomere length of blood cell in males, alongside increased Trf1 expression. Long telomeres in male blood cells were associated with reduced anxiety, while a positive correlation was found between Tpp1 expression and stereotypical behavior in both male and female VPA rats. These findings suggest that nooclerin and risperidone influence telomere length and gene expression related to the telomere-telomerase complex in a sex-dependent manner, offering insights into the neurobiological mechanisms underlying ASD. |
ArticleNumber | 55 |
Author | Nikitin, Dmitry O. Ahmetov, Ildus I. Valeeva, Elena V. Semina, Irina I. Nikiforova, Lubov S. |
Author_xml | – sequence: 1 givenname: Elena V. surname: Valeeva fullname: Valeeva, Elena V. organization: Central Research Laboratory, Kazan State Medical University, Laboratory of Genetics of Aging and Longevity, Kazan State Medical University – sequence: 2 givenname: Dmitry O. surname: Nikitin fullname: Nikitin, Dmitry O. organization: Pharmacology Department, Kazan State Medical University – sequence: 3 givenname: Lubov S. surname: Nikiforova fullname: Nikiforova, Lubov S. organization: Central Research Laboratory, Kazan State Medical University – sequence: 4 givenname: Irina I. surname: Semina fullname: Semina, Irina I. organization: Central Research Laboratory, Kazan State Medical University, Pharmacology Department, Kazan State Medical University – sequence: 5 givenname: Ildus I. orcidid: 0000-0002-6335-4020 surname: Ahmetov fullname: Ahmetov, Ildus I. email: i.akhmetov@ljmu.ac.uk organization: Central Research Laboratory, Kazan State Medical University, Laboratory of Genetics of Aging and Longevity, Kazan State Medical University, Research Institute for Sport and Exercise Sciences, Liverpool John Moores University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40272729$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ks-OFCEQxolZ4_7RF_BgSLx4aZeC7hn6ZDabcTUZo1nHM6Hp6mk2NIxAG30DH1t2Z1xXD6ZCIOFXX1XBd0qOfPBIyHNgr4Gx5XkCzgRUjDdliUZU9SNyAk3TVgCLxdGD8zE5TemGMQ41yCfkuGZ8WaI9IT9Xw4AmJxoG-mnUcdImuLC1Rju6iajzhD7T4OkGXZgwIl2j3-aRat_TPCJdfd9FTMkWpEgcKJ3w_POILmO0vrpGpzP29Ao9Jmo9vdaZfgg9uruyF3O2aXpKHg_aJXx22M_Il7erzeW7av3x6v3lxboyNZe56pBxZEZDL5B1TOt6yUWnBZMG-4FjLRnKEih5L2XbNkZioY0E6DhvjDgjb_a6u7mbsDdlvKid2kU76fhDBW3V3zfejmobvqny2ByWQhSFVweFGL7OmLKabDLonPYY5qQEtDVfMAa36Mt_0JswR1_mU4KDaKBEU6gXD1u67-X3LxWA7wETQ0oRh3sEmLq1gtpbQRUrqDsrqLokiX1SKrDfYvxT-z9ZvwB5KbgQ |
Cites_doi | 10.15585/mmwr.ss7001a1 10.5498/wjp.v13.i6.262 10.1111/jnc.12255 10.3389/fnins.2021.641284 10.1007/s11055-023-01458-w 10.1016/j.vascn.2020.106676 10.1093/nar/30.10.e47 10.1016/j.schres.2015.04.025 10.1016/j.semcancer.2011.07.001 10.17116/jnevro201911911141 10.1016/j.cell.2006.04.044 10.1016/j.jpsychires.2017.01.002 10.1016/j.biopsych.2019.04.028 10.1016/S0892-0362(00)00028-3 10.1186/s13229-016-0073-0 10.1007/s12035-015-9296-5 10.1128/MCB.20.5.1659-1668.2000 10.1038/sj.onc.1207582 10.1001/jama.2022.23661 10.1093/jnci/dju408 10.5607/en.2017.26.5.252 10.1080/10408440590964217 10.1073/pnas.1607426113 10.1007/s12035-013-8535-2 10.1155/2019/5046867 10.1002/aur.2307 10.1038/s41588-022-01148-2 10.1007/s00109-002-0374-5 10.3390/ijms222111855 10.1158/1541-7786.mcr-05-0147 10.52600/2763-583X.bjcr.2023.3.1.16-23 10.1002/humu.21220 10.1002/hipo.23264 10.1016/j.jad.2015.11.052 10.1093/rheumatology/kez524 10.1073/pnas.2215632120 10.1016/j.arcmed.2022.09.006 10.1016/j.yfrne.2019.100818 10.1126/science.abn6840 10.1016/j.jaac.2013.11.014 10.1038/sj.npp.1300604 10.1016/j.pharmthera.2018.05.003 10.1186/2047-9158-2-17 10.1534/g3.112.004689 10.1111/j.1474-9726.2011.00741.x 10.1016/j.celrep.2014.10.022 10.1016/j.redox.2024.103278 10.1080/10715762.2021.2017913 10.1002/path.2500 10.1016/j.stemcr.2018.04.001 10.1182/blood-2014-04-568508 10.1016/j.neubiorev.2012.07.005 10.1016/j.schres.2008.04.003 10.3389/fpsyt.2023.1205199 10.1007/s10803-011-1215-z 10.1016/j.arr.2018.09.002 10.1007/s11033-010-0439-x 10.1016/j.tics.2012.09.006 10.1038/nrm2845 10.1038/srep07073 10.1038/nprot.2007.44 10.3389/fpsyt.2023.1209638 10.3791/50978 10.1038/tp.2015.125 10.1093/nar/gkg224 10.1016/j.neuropharm.2012.07.028 10.17750/KMJ2019-100-6-918 10.1006/meth.2001.1127 10.1016/j.csbj.2020.06.040 10.1016/j.mad.2022.111694 10.1038/sj.leu.2403086 10.1016/j.rasd.2022.102067 10.1016/j.exger.2013.12.004 10.1007/s10803-022-05486-2 10.1371/journal.pgen.1007782 10.1038/35011073 10.4103/1673-5374.324852 |
ContentType | Journal Article |
Copyright | The Author(s) 2025 2025. The Author(s). Copyright Springer Nature B.V. Jun 2025 The Author(s) 2025 2025 |
Copyright_xml | – notice: The Author(s) 2025 – notice: 2025. The Author(s). – notice: Copyright Springer Nature B.V. Jun 2025 – notice: The Author(s) 2025 2025 |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL 7QR 7T7 7TK 7U9 8FD C1K FR3 H94 K9. M7N P64 7X8 5PM |
DOI | 10.1007/s12031-025-02353-4 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Technology Research Database Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Chemoreception Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE Virology and AIDS Abstracts MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1559-1166 |
ExternalDocumentID | PMC12021733 40272729 10_1007_s12031_025_02353_4 |
Genre | Journal Article |
GeographicLocations | Russia |
GeographicLocations_xml | – name: Russia |
GrantInformation_xml | – fundername: Russian Science Foundation grantid: 23-25-00325; 23-25-00325; 23-25-00325; 23-25-00325 funderid: http://dx.doi.org/10.13039/501100006769 – fundername: Russian Science Foundation grantid: 23-25-00325 |
GroupedDBID | --- .86 .VR 06C 06D 0R~ 0VY 1N0 203 29L 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2~H 30V 4.4 406 408 40D 40E 53G 5GY 5RE 5VS 67N 6NX 78A 7X7 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANZL AAPKM AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYZH ABAKF ABBRH ABDBE ABDZT ABECU ABFSG ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTHY ABTKH ABTMW ABWNU ABXPI ACAOD ACCUX ACDTI ACGFS ACHSB ACHXU ACIWK ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACSNA ACSTC ACZOJ ADBBV ADHHG ADHIR ADKNI ADKPE ADTPH ADURQ ADYFF ADZKW AEFQL AEGAL AEGNC AEJHL AEJRE AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AEZWR AFBBN AFDZB AFHIU AFLOW AFOHR AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHMBA AHPBZ AHSBF AHWEU AIAKS AIGIU AIIXL AILAN AITGF AIXLP AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ATHPR AXYYD AYFIA B-. BA0 BENPR BGNMA BSONS C6C CS3 CSCUP DDRTE DNIVK DPUIP DU5 EBLON EBS EIOEI ESBYG F5P FERAY FFXSO FIGPU FNLPD FRRFC FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ7 HF~ HG6 HMJXF HRMNR IJ- IKXTQ ITM IWAJR I~X I~Z J-C J0Z JBSCW JZLTJ KOV LLZTM M4Y MA- N9A NF0 NPVJJ NQJWS NU0 O93 O9G O9I O9J P19 P2P PF0 PT4 PT5 QOK QOR QOS R89 R9I RNS ROL RPX RSV S16 S1Z S27 S3A S3B SAP SBL SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SZN T13 TSG TUC U2A U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW W48 WK8 YLTOR ZMTXR ZOVNA ~A9 ~EX AAYXX CITATION ABRTQ CGR CUY CVF ECM EIF NPM 7QL 7QR 7T7 7TK 7U9 8FD C1K FR3 H94 K9. M7N P64 7X8 5PM TUS |
ID | FETCH-LOGICAL-c428t-be02e0ca1d3e0b0aa4723ba308cedf2e480e8e8ee82d88995c8eca1c811b225c3 |
IEDL.DBID | U2A |
ISSN | 1559-1166 0895-8696 |
IngestDate | Thu Aug 21 18:26:48 EDT 2025 Fri Jul 11 18:30:40 EDT 2025 Sun Jul 27 04:10:36 EDT 2025 Mon Jul 21 06:03:33 EDT 2025 Thu Jul 03 08:15:08 EDT 2025 Wed Jul 02 02:43:57 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Nooclerin Autism Amitriptyline Risperidone Expression genes Telomere |
Language | English |
License | 2025. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c428t-be02e0ca1d3e0b0aa4723ba308cedf2e480e8e8ee82d88995c8eca1c811b225c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-6335-4020 |
OpenAccessLink | https://link.springer.com/10.1007/s12031-025-02353-4 |
PMID | 40272729 |
PQID | 3213515155 |
PQPubID | 326248 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_12021733 proquest_miscellaneous_3194260013 proquest_journals_3213515155 pubmed_primary_40272729 crossref_primary_10_1007_s12031_025_02353_4 springer_journals_10_1007_s12031_025_02353_4 |
PublicationCentury | 2000 |
PublicationDate | 2025-04-24 |
PublicationDateYYYYMMDD | 2025-04-24 |
PublicationDate_xml | – month: 04 year: 2025 text: 2025-04-24 day: 24 |
PublicationDecade | 2020 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: United States – name: Totowa |
PublicationSubtitle | MN |
PublicationTitle | Journal of molecular neuroscience |
PublicationTitleAbbrev | J Mol Neurosci |
PublicationTitleAlternate | J Mol Neurosci |
PublicationYear | 2025 |
Publisher | Springer US Springer Nature B.V |
Publisher_xml | – name: Springer US – name: Springer Nature B.V |
References | WQ Fang (2353_CR18) 2014; 9 DP Kennedy (2353_CR31) 2012; 16 J Hellings (2353_CR26) 2023; 13 D Hockemeyer (2353_CR28) 2006; 126 Z Zeng (2353_CR81) 2020; 59 P Sołek (2353_CR70) 2021; 22 M Cirnigliaro (2353_CR13) 2023; 120 F Mamdani (2353_CR46) 2015; 5 A Smogorzewska (2353_CR69) 2000; 20 L Mirabello (2353_CR48) 2010; 31 T Aramburu (2353_CR3) 2020; 18 RJ O’Sullivan (2353_CR52) 2010; 11 2353_CR49 2353_CR45 EH Blackburn (2353_CR8) 2005; 3 GB Polho (2353_CR57) 2015; 165 TW Frazier (2353_CR20) 2014; 53 NA Bondarenko (2353_CR9) 2017; 4 Y Panahi (2353_CR55) 2023; 53 SM Banker (2353_CR5) 2021; 31 KK Ridout (2353_CR60) 2016; 191 J Wiltse (2353_CR77) 2005; 35 T Hirota (2353_CR27) 2023; 329 Z Sekne (2353_CR63) 2022; 375 M Solomon (2353_CR71) 2012; 42 T Zhang (2353_CR82) 2023; 14 GE Hodes (2353_CR29) 2019; 86 JL Ingram (2353_CR30) 2000; 22 2353_CR53 AA Walf (2353_CR74) 2007; 2 2353_CR10 2353_CR54 WY Yu (2353_CR80) 2008; 33 II Semina (2353_CR64) 2019; 100 JK Kern (2353_CR32) 2013; 2 NF Mathon (2353_CR47) 2001; 1 JW Shay (2353_CR67) 2011; 21 2353_CR15 A Rynkiewicz (2353_CR61) 2016; 7 Zhou, X., Feliciano, P., Shu, C., Wang, T., Astrovskaya, I., Hall, J. B., Obiajulu, J. U., Wright, J. R., Murali, S. C., Xu, S. X., Brueggeman, L., Thomas, T. R., Marchenko, O., Fleisch, C., Barns, S. D., Snyder, L. G., Han, B., Chang, T. S., Turner, T. N., Harvey, W. T., Nishida, A., O'Roak, B. J., Geschwind, D. H., SPARK Consortium, Michaelson, J. J., Volfovsky, N., Eichler, E. E., Shen, Y., & Chung, W. K (2353_CR83) 2022; 54 T Schneider (2353_CR62) 2005; 30 S Gao (2353_CR21) 2024; 75 JM Hansen (2353_CR25) 2021; 55 KC Kim (2353_CR36) 2013; 124 H Cherif (2353_CR12) 2003; 31 K Bisht (2353_CR7) 2016; 113 CR Lewis (2353_CR40) 2020; 13 W Klapper (2353_CR38) 2003; 17 N Monroy-Jaramillo (2353_CR50) 2017; 90 RM Cawthon (2353_CR11) 2002; 30 KJ Livak (2353_CR44) 2001; 25 B Porton (2353_CR58) 2008; 106 CA Finney (2353_CR19) 2020; 56 II Semina (2353_CR65) 2023; 53 H Liu (2353_CR43) 2021; 15 SR Sharma (2353_CR66) 2018; 190 X Xu (2353_CR79) 2019; 2019 KC Kim (2353_CR33) 2017; 26 Q Wang (2353_CR76) 2018; 48 G De Boeck (2353_CR16) 2009; 217 X Lin (2353_CR42) 2022; 99 M Angoa-Pérez (2353_CR1) 2013; 24 Z Li (2353_CR41) 2014; 4 PV Dixit (2353_CR17) 2020; 102 KC Kim (2353_CR34) 2016; 53 2353_CR73 PM Lansdorp (2353_CR39) 2022; 53 2353_CR72 A Wojtyla (2353_CR78) 2011; 38 HS Go (2353_CR23) 2012; 63 LG Aoude (2353_CR2) 2015; 107 S Coghlan (2353_CR14) 2012; 36 AK Mukherjee (2353_CR51) 2018; 14 Y Guo (2353_CR24) 2014; 124 2353_CR37 ELB Barrett (2353_CR6) 2011; 10 Gardner, M., Bann, D., Wiley, L., Cooper, R., Hardy, R., Nitsch, D., Martin-Ruiz, C., Shiels, P., Sayer, A.A., Barbieri, M., Bekaert, S., Bischoff, C., Brooks-Wilson, A., Chen, W., Cooper, C., Christensen, K., Meyer, T.D., Deary, I., Der, G., Roux, A. D., Fitzpatrick, A., Hajat, A., Halaschek-Wiener, J., Harris, S., Hunt, C., Jagger, C., Jeon, H.-S., Kaplan, R., Kimura, M., Lansdorp, P., Li, C., Maeda, T., Mangino, M., Nawrot, T.S., Nilsson, P., Nordfjall, K., Paolisso, G., Ren, F., Riabowol, K., Robertson, T., Roos, G., Staessen, J. A., Spector, T., Tang, N., Unryn, B., Harst, P., Woo, J., Xing, C., Yadegarfar, M. E., Park J. Y., Young, N., Kuh, D., von Zglinicki T., Ben-Shlomo Y., Halcyon Study Team (2353_CR22) 2014; 51 L Wang (2353_CR75) 2015; 8 EM Shipilova (2353_CR68) 2019; 119 A Aviv (2353_CR4) 2002; 80 KC Kim (2353_CR35) 2014; 49 GB Polho (2353_CR56) 2022; 17 A Prasad (2353_CR59) 2012; 2 |
References_xml | – ident: 2353_CR45 doi: 10.15585/mmwr.ss7001a1 – volume: 13 start-page: 262 issue: 6 year: 2023 ident: 2353_CR26 publication-title: World Journal of Psychiatry doi: 10.5498/wjp.v13.i6.262 – volume: 124 start-page: 832 issue: 6 year: 2013 ident: 2353_CR36 publication-title: J Neurochem doi: 10.1111/jnc.12255 – volume: 15 year: 2021 ident: 2353_CR43 publication-title: Front Neurosci doi: 10.3389/fnins.2021.641284 – volume: 53 start-page: 597 issue: 4 year: 2023 ident: 2353_CR65 publication-title: Neurosci Behav Physiol doi: 10.1007/s11055-023-01458-w – ident: 2353_CR73 – volume: 102 year: 2020 ident: 2353_CR17 publication-title: J Pharmacol Toxicol Methods doi: 10.1016/j.vascn.2020.106676 – volume: 30 start-page: e47 issue: 10 year: 2002 ident: 2353_CR11 publication-title: Nucleic Acids Res doi: 10.1093/nar/30.10.e47 – volume: 165 start-page: 195 issue: 2–3 year: 2015 ident: 2353_CR57 publication-title: Schizophr Res doi: 10.1016/j.schres.2015.04.025 – ident: 2353_CR54 – volume: 21 start-page: 349 year: 2011 ident: 2353_CR67 publication-title: Semin Cancer Biol doi: 10.1016/j.semcancer.2011.07.001 – volume: 119 start-page: 41 issue: 11 year: 2019 ident: 2353_CR68 publication-title: Zhurnal Nevrologii i Psikhiatrii Imeni S.S Korsakova doi: 10.17116/jnevro201911911141 – volume: 126 start-page: 63 issue: 1 year: 2006 ident: 2353_CR28 publication-title: Cell doi: 10.1016/j.cell.2006.04.044 – volume: 90 start-page: 26 year: 2017 ident: 2353_CR50 publication-title: J Psychiatr Res doi: 10.1016/j.jpsychires.2017.01.002 – volume: 86 start-page: 421 issue: 6 year: 2019 ident: 2353_CR29 publication-title: Biological Psychiatry doi: 10.1016/j.biopsych.2019.04.028 – volume: 22 start-page: 319 issue: 3 year: 2000 ident: 2353_CR30 publication-title: Neurotoxicol Teratol doi: 10.1016/S0892-0362(00)00028-3 – volume: 7 start-page: 1 year: 2016 ident: 2353_CR61 publication-title: Molecular Autism doi: 10.1186/s13229-016-0073-0 – volume: 53 start-page: 40 year: 2016 ident: 2353_CR34 publication-title: Mol Neurobiol doi: 10.1007/s12035-015-9296-5 – volume: 20 start-page: 1659 issue: 5 year: 2000 ident: 2353_CR69 publication-title: Mol Cell Biol doi: 10.1128/MCB.20.5.1659-1668.2000 – ident: 2353_CR37 doi: 10.1038/sj.onc.1207582 – volume: 329 start-page: 157 issue: 2 year: 2023 ident: 2353_CR27 publication-title: JAMA doi: 10.1001/jama.2022.23661 – volume: 107 start-page: dju408 issue: 2 year: 2015 ident: 2353_CR2 publication-title: Journal of the National Cancer Institute doi: 10.1093/jnci/dju408 – volume: 26 start-page: 252 issue: 5 year: 2017 ident: 2353_CR33 publication-title: Experimental Neurobiology doi: 10.5607/en.2017.26.5.252 – volume: 8 start-page: 578 issue: 1 year: 2015 ident: 2353_CR75 publication-title: Int J Clin Exp Pathol – volume: 35 start-page: 727 issue: 8–9 year: 2005 ident: 2353_CR77 publication-title: Crit Rev Toxicol doi: 10.1080/10408440590964217 – volume: 113 start-page: 13021 issue: 46 year: 2016 ident: 2353_CR7 publication-title: Proc Natl Acad Sci doi: 10.1073/pnas.1607426113 – volume: 49 start-page: 512 issue: 1 year: 2014 ident: 2353_CR35 publication-title: Mol Neurobiol doi: 10.1007/s12035-013-8535-2 – volume: 2019 start-page: 5046867 year: 2019 ident: 2353_CR79 publication-title: Biomed Res Int doi: 10.1155/2019/5046867 – volume: 13 start-page: 1094 issue: 7 year: 2020 ident: 2353_CR40 publication-title: Autism Res doi: 10.1002/aur.2307 – volume: 54 start-page: 1305 issue: 9 year: 2022 ident: 2353_CR83 publication-title: Nat Genet doi: 10.1038/s41588-022-01148-2 – volume: 80 start-page: 689 year: 2002 ident: 2353_CR4 publication-title: J Mol Med doi: 10.1007/s00109-002-0374-5 – volume: 4 start-page: 45 issue: 4 year: 2017 ident: 2353_CR9 publication-title: Cognitive Science in Moscow – volume: 22 start-page: 11855 issue: 21 year: 2021 ident: 2353_CR70 publication-title: Int J Mol Sci doi: 10.3390/ijms222111855 – volume: 3 start-page: 477 issue: 4 year: 2005 ident: 2353_CR8 publication-title: Mol Cancer Res doi: 10.1158/1541-7786.mcr-05-0147 – ident: 2353_CR15 doi: 10.52600/2763-583X.bjcr.2023.3.1.16-23 – volume: 31 start-page: 1050 issue: 9 year: 2010 ident: 2353_CR48 publication-title: Hum Mutat doi: 10.1002/humu.21220 – volume: 31 start-page: 79 issue: 1 year: 2021 ident: 2353_CR5 publication-title: Hippocampus doi: 10.1002/hipo.23264 – volume: 191 start-page: 237 year: 2016 ident: 2353_CR60 publication-title: J Affect Disord doi: 10.1016/j.jad.2015.11.052 – volume: 59 start-page: 940 issue: 5 year: 2020 ident: 2353_CR81 publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/kez524 – volume: 120 issue: 31 year: 2023 ident: 2353_CR13 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.2215632120 – volume: 53 start-page: 741 issue: 8 year: 2022 ident: 2353_CR39 publication-title: Arch Med Res doi: 10.1016/j.arcmed.2022.09.006 – volume: 56 year: 2020 ident: 2353_CR19 publication-title: Front Neuroendocrinol doi: 10.1016/j.yfrne.2019.100818 – volume: 375 start-page: 1173 issue: 6585 year: 2022 ident: 2353_CR63 publication-title: Science doi: 10.1126/science.abn6840 – volume: 53 start-page: 329 issue: 3 year: 2014 ident: 2353_CR20 publication-title: J Am Acad Child Adolesc Psychiatry doi: 10.1016/j.jaac.2013.11.014 – volume: 30 start-page: 80 issue: 1 year: 2005 ident: 2353_CR62 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300604 – volume: 190 start-page: 91 year: 2018 ident: 2353_CR66 publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2018.05.003 – volume: 2 start-page: 1 issue: 1 year: 2013 ident: 2353_CR32 publication-title: Translational Neurodegeneration doi: 10.1186/2047-9158-2-17 – volume: 2 start-page: 1665 issue: 12 year: 2012 ident: 2353_CR59 publication-title: G3: Genes, Genomes, Genetics doi: 10.1534/g3.112.004689 – volume: 10 start-page: 913 issue: 6 year: 2011 ident: 2353_CR6 publication-title: Aging Cell doi: 10.1111/j.1474-9726.2011.00741.x – volume: 9 start-page: 1635 issue: 5 year: 2014 ident: 2353_CR18 publication-title: Cell Rep doi: 10.1016/j.celrep.2014.10.022 – volume: 33 start-page: 244 year: 2008 ident: 2353_CR80 publication-title: J Psychiatry Neurosci – volume: 75 year: 2024 ident: 2353_CR21 publication-title: Redox Biol doi: 10.1016/j.redox.2024.103278 – volume: 55 start-page: 1130 issue: 11–12 year: 2021 ident: 2353_CR25 publication-title: Free Radical Res doi: 10.1080/10715762.2021.2017913 – volume: 217 start-page: 327 issue: 3 year: 2009 ident: 2353_CR16 publication-title: J Pathol doi: 10.1002/path.2500 – ident: 2353_CR53 doi: 10.1016/j.stemcr.2018.04.001 – volume: 124 start-page: 2767 issue: 18 year: 2014 ident: 2353_CR24 publication-title: Blood doi: 10.1182/blood-2014-04-568508 – volume: 36 start-page: 2044 issue: 9 year: 2012 ident: 2353_CR14 publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2012.07.005 – volume: 106 start-page: 242 issue: 2–3 year: 2008 ident: 2353_CR58 publication-title: Schizophr Res doi: 10.1016/j.schres.2008.04.003 – ident: 2353_CR49 doi: 10.3389/fpsyt.2023.1205199 – volume: 42 start-page: 48 year: 2012 ident: 2353_CR71 publication-title: J Autism Dev Disord doi: 10.1007/s10803-011-1215-z – volume: 48 start-page: 11 year: 2018 ident: 2353_CR76 publication-title: Ageing Res Rev doi: 10.1016/j.arr.2018.09.002 – volume: 38 start-page: 3339 year: 2011 ident: 2353_CR78 publication-title: Mol Biol Rep doi: 10.1007/s11033-010-0439-x – volume: 16 start-page: 559 issue: 11 year: 2012 ident: 2353_CR31 publication-title: Trends Cogn Sci doi: 10.1016/j.tics.2012.09.006 – volume: 11 start-page: 171 issue: 3 year: 2010 ident: 2353_CR52 publication-title: Nat Rev Mol Cell Biol doi: 10.1038/nrm2845 – volume: 4 start-page: 7073 year: 2014 ident: 2353_CR41 publication-title: Sci Rep doi: 10.1038/srep07073 – volume: 2 start-page: 322 issue: 2 year: 2007 ident: 2353_CR74 publication-title: Nat Protoc doi: 10.1038/nprot.2007.44 – volume: 14 start-page: 1209638 year: 2023 ident: 2353_CR82 publication-title: Front Psych doi: 10.3389/fpsyt.2023.1209638 – volume: 24 start-page: 50978 issue: 82 year: 2013 ident: 2353_CR1 publication-title: J vis Exp doi: 10.3791/50978 – volume: 5 start-page: e636 issue: 9 year: 2015 ident: 2353_CR46 publication-title: Translational psychiatry doi: 10.1038/tp.2015.125 – volume: 31 start-page: 1576 issue: 5 year: 2003 ident: 2353_CR12 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkg224 – volume: 63 start-page: 1028 issue: 6 year: 2012 ident: 2353_CR23 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2012.07.028 – ident: 2353_CR72 – volume: 100 start-page: 918 issue: 6 year: 2019 ident: 2353_CR64 publication-title: Kazan medical journal doi: 10.17750/KMJ2019-100-6-918 – volume: 25 start-page: 402 issue: 4 year: 2001 ident: 2353_CR44 publication-title: Methods doi: 10.1006/meth.2001.1127 – volume: 18 start-page: 1939 year: 2020 ident: 2353_CR3 publication-title: Comput Struct Biotechnol J doi: 10.1016/j.csbj.2020.06.040 – ident: 2353_CR10 doi: 10.1016/j.mad.2022.111694 – volume: 17 start-page: 2007 issue: 10 year: 2003 ident: 2353_CR38 publication-title: Leukemia doi: 10.1038/sj.leu.2403086 – volume: 99 year: 2022 ident: 2353_CR42 publication-title: Research in Autism Spectrum Disorders doi: 10.1016/j.rasd.2022.102067 – volume: 51 start-page: 15 year: 2014 ident: 2353_CR22 publication-title: Exp Gerontol doi: 10.1016/j.exger.2013.12.004 – volume: 53 start-page: 2050 issue: 5 year: 2023 ident: 2353_CR55 publication-title: J Autism Dev Disord doi: 10.1007/s10803-022-05486-2 – volume: 14 issue: 11 year: 2018 ident: 2353_CR51 publication-title: PLoS Genet doi: 10.1371/journal.pgen.1007782 – volume: 1 start-page: 203 year: 2001 ident: 2353_CR47 publication-title: Nat Rev Cancer doi: 10.1038/35011073 – volume: 17 start-page: 1156 issue: 5 year: 2022 ident: 2353_CR56 publication-title: Neural Regen Res doi: 10.4103/1673-5374.324852 |
SSID | ssj0021418 |
Score | 2.418945 |
Snippet | Telomeres are increasingly recognized for their potential role in the etiology of autism spectrum disorder (ASD) due to their involvement in cellular aging and... |
SourceID | pubmedcentral proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 55 |
SubjectTerms | Amitriptyline Animal models Animals Antipsychotic Agents - pharmacology Antipsychotic Agents - therapeutic use Autism Biomedical and Life Sciences Biomedicine Blood Blood cells Cell Biology Drug therapy Female Gene expression Genes Hippocampus - drug effects Hippocampus - metabolism Male Males Neurochemistry Neurology Neurosciences Prefrontal cortex Prefrontal Cortex - drug effects Prefrontal Cortex - metabolism Proteomics Rats Rats, Wistar Risperidone Risperidone - pharmacology Risperidone - therapeutic use Shelterin Complex Telomerase Telomerase - genetics Telomerase - metabolism Telomere - drug effects Telomere - metabolism Telomere Homeostasis - drug effects Telomere-binding protein Telomere-Binding Proteins - genetics Telomere-Binding Proteins - metabolism Telomeres TRF2 protein Valproic acid Valproic Acid - toxicity |
Title | Effects of Pharmacological Treatment on Telomere Length and the Expression of Telomerase/Shelterin-Related Genes in Rat Models of Autism |
URI | https://link.springer.com/article/10.1007/s12031-025-02353-4 https://www.ncbi.nlm.nih.gov/pubmed/40272729 https://www.proquest.com/docview/3213515155 https://www.proquest.com/docview/3194260013 https://pubmed.ncbi.nlm.nih.gov/PMC12021733 |
Volume | 75 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Nb9QwELVoe-GCoOUj0K6MhLiARWI7u84xWm2pAHGAXamcIjuesCt1napJJfoP-rMZe5OsltJDlVsysR29sT2TGb8h5B2iWlaq9FnimjNZJYKpDDjj2lgjJddjHbJ8v4_PFvLLeXreHQpr-mz3PiQZVurtYTeOCsh8-VXP0SKY3CMHqffdUYsXPB_crEQmqjse8__3dregO3bl3fTIf2KkYes5fUqedDYjzTcgPyOPwB2So9yhv7y-oe9pyOIMv8ePyO2GjrihdYX3B1pqDwWd90nltHZ0Dhf1Gq6AfgP3u11S7SxFY5DO_nSpsc430UnhVvfp5xJ8ZH3lWEigA0s9ZXVDV47-0C31RdUuQrc56nKzfk4Wp7P59Ix11RZYiS5IywzEHOJSJ1ZAbGKt5YQLo0WsSrAVB6liUHiB4lahl5aWClC6VElicFEoxQuy72oHrwg1wLNK6LG1JpU2M2qiYm4mcWJLRECnEfnQA1Bcbkg1ii19soerQLiKAFchI3LcY1R0E6wpBPelBX19moi8HR7j1PDxDu2gvkaZJAv8-4mIyMsNpEN36Db7EHQWEbUD9iDgabd3n7jVMtBv4wDRjxPY6MdeL7bjuv8zXj9M_A15zIPOSsblMdlvr67hBO2f1ozIQf7519fZiOxNx9NRUP6_0tsDNQ |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagHOBSAeURKGAkxAWsxo_ddY6rVasFlh5gK_UW-TFhV-o6VZNK9B_0ZzP2ZlNtCweUWzyxHX3jeCYz_oaQD4iqq7SLWeJGMFVxyXQBggljvVVKmKFJWb7Hw-mJ-no6OO1ocuJZmFvx-4OGC1Q7FouuRmYWydR98kChpxzT9ybDSe9cccV1dyjm789tbzx3rMm7SZG3IqNpwzl6THY7S5GO19A-IfcgPCV744Be8uqKfqQpdzP9FN8j12sS4obWFd7vyagjAHS-SSWndaBzOKtXcAF0BuFXu6AmeIomID383SXEhthFJ4Ub3MHPBcR4-jKwlDYHnkai6oYuA_1hWhpLqZ2lYceowc3qGTk5OpxPpqyrscAcOh4ts5ALyJ3hXkJuc2PUSEhrZK4d-EqA0jlovEALr9E3GzgNKO005xY_BU4-JzuhDvCSUAuiqKQZem8HyhdWj3Qu7Cjn3iECZpCRTxsAyvM1lUZ5Q5oc4SoRrjLBVaqM7G8wKrtl1ZRSxIKCsSpNRt73zbggYpTDBKgvUYYXiXWfy4y8WEPaD4fOcgw8FxnRW2D3ApFse7slLBeJdBsniN6bxE4_b_TiZl7_fo1X_yf-jjyczr_PytmX42-vySOR9FcxofbJTntxCW_QAmrt26T6fwBc3_-H |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELdgSIiXCRgfGQOMhHgBq_FHW-exKqsGTBOCTtpbZMcXWml1pjWT4D_Yn72z81HK4AHlLb7Yjn7n2Je7-x0hbxHVotRFiBI3gqmSS6YzEEwY66xSwoxMjPI9GR2dqs9nw7PfsvhjtHvnkmxyGgJLk68HF64cbBLfBCojC6VYA1-LZOouuYeWSnTUTkfT3uTiius2Vebvz21vR7fOmLdDJf_wl8ZtaPaQ7LbnRzppAH9E7oB_TPYmHm3n1S_6jsaIzvirfI9cN9TEa1qVeL-nqA6w0HkXYE4rT-dwXq3gEugx-B_1ghrvKB4M6eHPNkzWhy5aKdz2Bt8XELzsS89iMB04Guir13Tp6TdT01Bg7TwOO0G9Xq-ekNPZ4Xx6xNrKC6xAc6RmFlIBaWG4k5Da1Bg1FtIameoCXClA6RQ0XqCF02ixDQsNKF1ozi1-IAr5lOz4ysNzQi2IrJRm5JwdKpdZPdapsOOUuwIRMMOEvO8AyC8ago18Q6Uc4MoRrjzClauEHHQY5e1iW-dShDKDoVZNQt70zbhMgu_DeKiuUIZnkYufy4Q8ayDth0MTOrijs4ToLbB7gUDBvd3il4tIxY0TRJtOYqcfOr3YzOvfr7H_f-Kvyf2vH2f58aeTLy_IAxHVVzGhDshOfXkFL_FYVNtXUfNvAGbMB90 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+Pharmacological+Treatment+on+Telomere+Length+and+the+Expression+of+Telomerase%2FShelterin-Related+Genes+in+Rat+Models+of+Autism&rft.jtitle=Journal+of+molecular+neuroscience&rft.au=Valeeva%2C+Elena+V&rft.au=Nikitin%2C+Dmitry+O&rft.au=Nikiforova%2C+Lubov+S&rft.au=Semina%2C+Irina+I&rft.date=2025-04-24&rft.pub=Springer+Nature+B.V&rft.issn=0895-8696&rft.eissn=1559-1166&rft.volume=75&rft.issue=2&rft.spage=55&rft_id=info:doi/10.1007%2Fs12031-025-02353-4&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1559-1166&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1559-1166&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1559-1166&client=summon |